DE69011692D1 - Therapeutische mittel. - Google Patents

Therapeutische mittel.

Info

Publication number
DE69011692D1
DE69011692D1 DE69011692T DE69011692T DE69011692D1 DE 69011692 D1 DE69011692 D1 DE 69011692D1 DE 69011692 T DE69011692 T DE 69011692T DE 69011692 T DE69011692 T DE 69011692T DE 69011692 D1 DE69011692 D1 DE 69011692D1
Authority
DE
Germany
Prior art keywords
formula
compound
ace
inhibitor
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69011692T
Other languages
English (en)
Other versions
DE69011692T2 (de
Inventor
Patrick O'connor
Charles Defesche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Publication of DE69011692D1 publication Critical patent/DE69011692D1/de
Application granted granted Critical
Publication of DE69011692T2 publication Critical patent/DE69011692T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DE69011692T 1989-03-15 1990-03-12 Therapeutische mittel. Expired - Fee Related DE69011692T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32421389A 1989-03-15 1989-03-15
PCT/EP1990/000430 WO1990010445A1 (en) 1989-03-15 1990-03-12 Therapeutic agents

Publications (2)

Publication Number Publication Date
DE69011692D1 true DE69011692D1 (de) 1994-09-22
DE69011692T2 DE69011692T2 (de) 1994-12-01

Family

ID=23262607

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69011692T Expired - Fee Related DE69011692T2 (de) 1989-03-15 1990-03-12 Therapeutische mittel.

Country Status (13)

Country Link
EP (1) EP0527720B1 (de)
JP (1) JPH04503806A (de)
KR (1) KR920700642A (de)
AT (1) ATE109981T1 (de)
AU (1) AU640128B2 (de)
CA (1) CA2049980A1 (de)
DE (1) DE69011692T2 (de)
DK (1) DK0527720T3 (de)
ES (1) ES2057542T3 (de)
IE (1) IE65902B1 (de)
IL (1) IL93744A (de)
WO (1) WO1990010445A1 (de)
ZA (1) ZA901945B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994002144A1 (en) * 1992-07-21 1994-02-03 The Boots Company Plc Use of 7-fluoro-1-methyl-3-methylsulphinyl-4-quinolone in the treatment of angina pectoris

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3542794A1 (de) * 1985-12-04 1987-06-11 Bayer Ag Antihypertensives kombinationspraeparat

Also Published As

Publication number Publication date
WO1990010445A1 (en) 1990-09-20
IE65902B1 (en) 1995-11-29
KR920700642A (ko) 1992-08-10
EP0527720A1 (de) 1993-02-24
DK0527720T3 (da) 1994-12-05
JPH04503806A (ja) 1992-07-09
ES2057542T3 (es) 1994-10-16
CA2049980A1 (en) 1990-09-16
ATE109981T1 (de) 1994-09-15
AU5261690A (en) 1990-10-09
EP0527720B1 (de) 1994-08-17
IL93744A (en) 1995-06-29
ZA901945B (en) 1991-01-30
AU640128B2 (en) 1993-08-19
IL93744A0 (en) 1990-12-23
DE69011692T2 (de) 1994-12-01
IE900818L (en) 1990-09-15

Similar Documents

Publication Publication Date Title
ES2145913T3 (es) Inhibidores de metaloproteasas.
GEP20033131B (en) Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
BR9814498A (pt) Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
PH27446A (en) Compound with gastric acid inhibitory effect
GEP19991872B (en) Novel Taxoids, Preparations Thereof, and Pharmaceutical Compositions Containing Same
AR011437A1 (es) Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.
DE69011692T2 (de) Therapeutische mittel.
EP1027051A4 (de) Antithrombotische mittel
EP0980366A4 (de) Antithrombosemittel
GEP20012366B (en) Thienyl-, Furil-, Pyrrolyl- and Biphenyl-Sulfonamides, Their Derivatives, Their Use in Medicinal Purposes, Pharmaceutical Composition Containing the Same and Method for Treatment

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee